Frailty as an Effect Modifier in Randomized Controlled Trials: A Systematic Review is a research paper published in Journal of General Internal Medicine (2024). On theSindex it has a DataRank of 0.708. It has been cited 18 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0.267
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institute of Health
Grant: R01AG071809
National Institute of Health
Grant: K24AG073527
National Institutes of Health
Grant: 1K24AG073527-01A1
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 5R01AG071809-04
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
FWCI
1.98
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals